Back to Search Start Over

Single-Dose Cholera Vaccine in Response to an Outbreak in Zambia

Authors :
Anne Laure Page
José María Eiros
Lorenzo Pezzoli
Elizabeth Chizema-Kawesha
Iza Ciglenecki
Marc Poncin
Eva Ferreras
Alexandre Blake
John Mwaba
Florent Uzzeni
Gideon Zulu
Andrew S. Azman
Savina Stoitsova
Micaela Serafini
Caroline Voute
Francisco J. Luquero
Kennedy Malama
Hugues Robert
Belem Matapo
Ankur Rakesh
Sandra Cohuet
Marie Laure Quilici
Orbrie Chewe
Epicentre [Paris] [Médecins Sans Frontières]
Zambian Ministry of Health
University Teaching Hospital [Lusaka] (UTH)
Médecins sans Frontières [Genève] (MSF)
European Programme for Intervention Epidemiology Training (EPIET)
European Centre for Disease Prevention and Control (ECDC)
World Health Organisation [Lusaka]
Organisation Mondiale de la Santé / World Health Organization Office (OMS / WHO)
University of Valladolid
Institut Pasteur [Paris]
World Health Organisation (WHO)
Johns Hopkins Bloomberg School of Public Health [Baltimore]
Johns Hopkins University (JHU)
Supported by Médecins sans Frontières, by a grant to Drs. Azman and Luquero from the DOVE project at Johns Hopkins Bloomberg School of Public Health, and by Institut Pasteur.
European Centre for Disease Prevention and Control [Stockholm, Sweden] (ECDC)
Institut Pasteur [Paris] (IP)
Source :
New England Journal of Medicine, New England Journal of Medicine, Massachusetts Medical Society, 2018, 378 (6), pp.577-579. ⟨10.1056/NEJMc1711583⟩, New England Journal of Medicine, 2018, 378 (6), pp.577-579. ⟨10.1056/NEJMc1711583⟩, UVaDOC. Repositorio Documental de la Universidad de Valladolid, instname
Publication Year :
2018
Publisher :
HAL CCSD, 2018.

Abstract

Producción Científica<br />Killed oral cholera vaccines (OCVs) are part of the standard response package to a cholera outbreak, although the two-dose regimen of vaccines that has been prequalified by the World Health Organization (WHO) poses challenges to timely and efficient reactive vaccination campaigns.1 Recent data suggest that the first dose alone provides short-term protection, similar to that of two doses, which may largely dictate the effect of OCVs during epidemics

Details

Language :
English
ISSN :
00284793 and 15334406
Database :
OpenAIRE
Journal :
New England Journal of Medicine, New England Journal of Medicine, Massachusetts Medical Society, 2018, 378 (6), pp.577-579. ⟨10.1056/NEJMc1711583⟩, New England Journal of Medicine, 2018, 378 (6), pp.577-579. ⟨10.1056/NEJMc1711583⟩, UVaDOC. Repositorio Documental de la Universidad de Valladolid, instname
Accession number :
edsair.doi.dedup.....52c4d108b332816ee0db0aabe237fad4
Full Text :
https://doi.org/10.1056/NEJMc1711583⟩